Several studies have demonstrated that CD82 inhibits EMT and metastasis of digestive tumor cells through binding to extracellular matrix (ECM)-related molecules such as integrin and metalloprotease, and subsequently regulating their downstream signal transductions. Here, CD82 is linked to digestive system neoplasm.